RSSS — Research Solutions Balance Sheet
0.000.00%
- $97.94m
- $85.99m
- $49.06m
- 81
- 43
- 46
- 59
Annual balance sheet for Research Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 11 | 10.6 | 13.5 | 6.1 | 12.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.72 | 5.25 | 6.15 | 6.88 | 7.19 |
| Prepaid Expenses | |||||
| Total Current Assets | 16.9 | 17 | 21.3 | 14.7 | 20 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.021 | 0.048 | 0.07 | 0.088 | 0.061 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 16.9 | 17 | 21.8 | 41.9 | 46.1 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.5 | 12.1 | 14.5 | 17.9 | 25.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.5 | 12.1 | 14.5 | 30.2 | 32.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.43 | 4.88 | 7.33 | 11.7 | 13.9 |
| Total Liabilities & Shareholders' Equity | 16.9 | 17 | 21.8 | 41.9 | 46.1 |
| Total Common Shares Outstanding |